Question

In: Finance

Sinclair​ Pharmaceuticals, a small drug​ company, develops a vaccine that will protect against Helicobacter pylori​,a bacteria...

Sinclair​ Pharmaceuticals, a small drug​ company, develops a vaccine that will protect against Helicobacter pylori​,a bacteria that is the cause of a number of diseases of the stomach. It is expected that Sinclair Pharmaceuticals will experience extremely high growth over the next three years and will reinvest all of its earnings in expanding the company over this time. Earnings were $ 1.25 per share before the development of the vaccine and are expected to grow by​ 40% per year for the next three years. After this​ time, it is expected growth will drop to 3% and stay there for the expected future. Four years from now Sinclair will pay dividends that are​ 75% of its earnings. If its equity cost of capital is 10%,

what is the value of a share of Sinclair Pharmaceuticals​ today?

37.85

22.75

28.44

36.97

Solutions

Expert Solution

The Correct Option is $28.44

Calculations And Explanations are given below

First of all we have calculate EPS and DPS of each given Years in the following table

Years

EPS

DPS

1

1.25*1.4   =1.75

0

2

1.75*1.4 =2.45

0

3

2.45*1.4 =3.43

0

4

3.43*1.03 =3.5329

3.5329*.75=2.6496

(i.e. D4=2.6496)

Since in the first stage of three years dividend is not paid so there there will be 0 cashflows in first three years.

Calculation of value of share at the end third year

Value at the end of third year= D4/(r-g)

Where

                D4= $2.6496

                r = 10% (Cost of capital)

                g = 3% ( growth rate after three years)

So the Value at the end of third year = $2.6496/(.10-.03)

                                                                                = 2.6496/.07

                                                                                = $ 37.85

Since it is value of share after 3 years so we have discout it by PVIF (10%, 3yrs) so that we will get value at beginning of first year

    i.e. Current value of share = Value after 3years/(r+1)3

                                                                                                = $37.85/(.10+1)3

                                                                                                = $37.85/(1.10)3

                                                                                                = $37.85/1.331

                                                                = $ 28.44

Hence the value of share is $ 28.44


Related Solutions

2. A new flu vaccine was developed to protect elderly people against viral infection during the...
2. A new flu vaccine was developed to protect elderly people against viral infection during the winter season. In 120 patients, 70 of the patients who were vaccinated. Of the 70 patients, 56 of the patients had no flu symptoms. 50 of the patients who were not vaccinated, 28 patients have no flu symptoms. a) Determine the confidence interval (CI) at 95% (z*=1.96) level for the probability that a patient had no flu symptoms when a new vaccine is used...
Headquartered in Montreal, Canada, Valeant Pharmaceuticals International is a multinational company that develops and markets prescription...
Headquartered in Montreal, Canada, Valeant Pharmaceuticals International is a multinational company that develops and markets prescription and non-prescription products in dermatology and neurology. The company is listed both on the NYSE and Toronto Stock Exchange. Its 2015 Income Statement reported the following line item. $Millions 2015 2014 2013 Loss of Extinguishment debt------------------ $20.0 $129.6 $65.0 a) What is a ‘Loss of extinguishment of debt’? When does such a loss occur? b) How is this loss calculated? c) How does this...
A pharmaceutical company develops a drug that the claim reduces the percentage of kids that are...
A pharmaceutical company develops a drug that the claim reduces the percentage of kids that are allergic to tree nuts . Suppose it is believed that 14% of kids are allergic to tree nuts. In a recent the company says that only 9% of kids that took the medication were allergic to tree nuts. The pharmaceutical company claims that that this drug has reduced the percentage of kids allergic to tree nuts. In a hypothesis test to test this claim...
Suppose that the pharmaceutical company Abstergo Industries successfully develops the first successful vaccine for COVID-19. If...
Suppose that the pharmaceutical company Abstergo Industries successfully develops the first successful vaccine for COVID-19. If the United States government implements regulation that requires Abstergo to sell vaccine doses at marginal cost (rather than charging a higher price as it otherwise would), this will reduce Abstergo’s profit from the vaccine by $12 billion and increase the well-being of vaccine consumers by $17 billion, creating an overall efficiency gain of $5 billion. Explain why this regulation would not result in a...
10.  HYPOTHESIS ABOUT DIFFERENCE IN PROPORTIONS Suppose the Acme Drug Company develops a new drug, designed to...
10.  HYPOTHESIS ABOUT DIFFERENCE IN PROPORTIONS Suppose the Acme Drug Company develops a new drug, designed to prevent colds. The company states that the drug is less effective on seniors than on children. To test this claim, they choose a simple random sample of 80 seniors and 70 children. At the end of a whole year, 16 of the seniors caught a cold; and 11 of the children caught a cold. Based on these findings, can we conclude that the drug...
You tested small discs that had chemicals in them against bacteria. We call these chemicals ____________________________.
You tested small discs that had chemicals in them against bacteria. We call these chemicals ____________________________.
Suppose that on Friday, a company announces a new vaccine with99% effectiveness against all variants,...
Suppose that on Friday, a company announces a new vaccine with 99% effectiveness against all variants, available in late 2021. What will happen to the price of 10 year Treasuries?A. The price fallsB. The price rises
A small biotech company develops a new treatment for a rare disease. The new treatment is...
A small biotech company develops a new treatment for a rare disease. The new treatment is patented and the company is the sole monopolist in its market. The company can sell the treatment to private pharmacies and public hospitals. Pharmacies’ demand for the treatment is QPD = 84 – 0.4PP while public hospitals’ demand for the treatment is QHD = 116 – 0.6PH. The marginal cost of the new treatment is MC = 20 +2Q. The legislature passes a new...
A pharmaceutical company develops drugs to increase apoptosis in cancer cells. Each candidate drug is tested...
A pharmaceutical company develops drugs to increase apoptosis in cancer cells. Each candidate drug is tested in mice, using an experiment design that has 90% power at a = 1%. 1) For every 1000 drugs that have no real effect, about how many will the company mistakenly conclude work? 2) For every 1000 drugs that actually work, about how many will the company correctly conclude work?
New Dawn pharma is considering the acquisition of a small biotech company—Sunset Pharmaceuticals. Sunset is developing...
New Dawn pharma is considering the acquisition of a small biotech company—Sunset Pharmaceuticals. Sunset is developing a new drug that, if successful, would revolutionize the treatment of pancreatic and/or liver cancer. Sunset is about to start Phase I of the clinical testing for the new drug. New Dawn estimates that if they acquired Sunset the costs associated with Phase I testing would be around $60 million. They believe the probability of successful Phase I testing is 30%. Phase 2 testing...
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT